Celldex Therapeutics, Inc.
DE ˙ DB ˙ US15117B2025
25,40 € ↑0,12 (0,47%)
2026-06-05
DEL PRIS
SecurityDE:TCE2 / Celldex Therapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership577,267 shares
Latest Disclosed Value $ 18,310,909
Northern Trust Corp reports 4.96% increase in ownership of TCE2 / Celldex Therapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 577,267 shares of Celldex Therapeutics, Inc. (DE:TCE2) valued at $14,778,035 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 549,998 shares of Celldex Therapeutics, Inc.. This represents a change in shares of 4.96% during the quarter. The current value of the position is $14,662,582 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 577,267 27,269 4.96 18,311 22.58 0.0005
2026-02-17 2025-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 549,998 -45,387 -7.62 14,938 -3.02 0.0004
2025-11-14 2025-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 595,385 19,510 3.39 15,403 31.43 0.0004
2025-08-13 2025-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 575,875 -1,486 -0.26 11,719 11.83 0.0016
2025-05-13 2025-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 577,361 -20,244 -3.39 10,479 -30.61 0.0016
2025-02-14 2024-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 597,605 34,885 6.20 15,101 -21.04 0.0021
2024-11-13 2024-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 562,720 17,126 3.14 19,127 -5.28 0.0031
2024-08-14 2024-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 545,594 -8,267 -1.49 20,192 -13.13 0.0034
2024-05-14 2024-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 553,861 109,056 24.52 23,246 31.77 0.0040
2024-02-13 2023-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 444,805 -29,115 -6.14 17,641 35.26 0.0032
2023-11-13 2023-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 473,920 -13,832 -2.84 13,042 -21.19 0.0025
2023-08-11 2023-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 487,752 7,199 1.50 16,549 -4.29 0.0032
2023-05-15 2023-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 480,553 45,941 10.57 17,290 -10.74 0.0034
2023-02-13 2022-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 434,612 12,371 2.93 19,371 63.20 0.0041
2022-11-14 2022-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 422,241 -1,426 -0.34 11,869 3.91 0.0027
2022-08-12 2022-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 423,667 -15,867 -3.61 11,422 -23.70 0.0024
2022-05-13 2022-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B202 439,534 -24,630 -5.31 14,970 -16.54 0.0026
2022-02-08 2021-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 464,164 5,051 1.10 17,936 -27.64 0.0029
2021-11-15 2021-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 459,113 46,850 11.36 24,788 79.81 0.0044
2021-08-13 2021-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 412,263 305,057 284.55 13,786 524.08 0.0024
2021-05-12 2021-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 107,206 12,217 12.86 2,209 32.75 0.0004
2021-02-11 2020-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 94,989 6,644 7.52 1,664 26.93 0.0003
2020-11-16 2020-09-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 88,345 31,045 54.18 1,311 76.21 0.0003
2020-08-14 2020-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 57,300 23,040 67.25 744 1,205.26 0.0002
2020-05-14 2020-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 34,260 -321 -0.93 57 -26.92 0.0000
2020-02-14 2019-12-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 34,581 5,154 17.51 78 23.81 0.0000
2019-11-13 2019-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B202 29,427 529 1.83 63 -18.18 0.0000
2019-08-13 2019-06-30 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 28,898 688 2.44 77 -44.60 0.0000
2019-05-13 2019-03-31 13F CELLDEX THERAPEUTICS INC COM NEW 15117B202 28,210 -346,924 -92.48 139 87.84 0.0000
2019-02-12 2018-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 375,134 -309,759 -45.23 74 -76.05 0.0000
2018-11-14 2018-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 684,893 -358,877 -34.38 309 -41.25 0.0001
2018-09-18 2018-06-30 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 1,043,770 -1,113,190 -51.61 526 -89.53 0.0001
2018-08-14 2018-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,049,807 -1,107,153 529
2018-05-09 2018-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,156,960 36,933 1.74 5,026 -16.51 0.0013
2018-02-14 2017-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,120,027 65,669 3.20 6,020 2.47 0.0015
2017-11-13 2017-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,054,358 33,561 1.66 5,875 17.69 0.0015
2017-08-11 2017-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 2,020,797 219,661 12.20 4,992 -23.22 0.0014
2017-05-12 2017-03-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,801,136 10,655 0.60 6,502 2.59 0.0019
2017-02-13 2016-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,790,481 103,268 6.12 6,338 -7.03 0.0019
2016-11-09 2016-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,687,213 346,149 25.81 6,817 15.80 0.0021
2016-08-12 2016-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,341,064 235,371 21.29 5,887 40.43 0.0019
2016-08-19 2016-03-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 1,105,693 3,617 0.33 4,192 -75.74 0.0014
2016-05-13 2016-03-31 13F Celldex Therapeutics In COMM 15117B103 1,105,693 4,180
2016-02-12 2015-12-31 13F Celldex Therapeutics In COMM 15117B103 1,102,076 16,034 1.48 17,281 50.98 0.0057
2015-11-12 2015-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,086,042 25,409 2.40 11,446 -57.21 0.0038
2015-08-13 2015-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,060,633 32,942 3.21 26,748 -6.61 0.0181
2015-05-14 2015-03-31 13F Celldex Therapeutics In COMM 15117B103 1,027,691 34,602 3.48 28,641 58.03 0.0086
2015-02-12 2014-12-31 13F Celldex Therapeutics In COM 15117B103 993,089 -20,784 -2.05 18,124 37.93 0.0055
2014-11-13 2014-09-30 13F Celldex Therapeutics In COMM 15117B103 1,013,873 -62,638 -5.82 13,140 -25.21 0.0041
2014-08-14 2014-06-30 13F CELLDEX THERAPEUTICS INC com 15117B103 1,076,511 -91,144 -7.81 17,569 -14.85 0.0055
2014-05-14 2014-03-31 13F CELLDEX THERAPEUTICS INC COMM 15117B103 1,167,655 -108,758 -8.52 20,633 -33.23 0.0065
2014-02-21 2013-12-31 13F/A-1 CELLDEX THERAPEUTICS INC COM 15117B103 1,276,413 134,242 11.75 30,902 -23.64 0.0099
2014-02-12 2013-12-31 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,276,413 30,902
2013-11-13 2013-09-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,142,171 -11,586 -1.00 40,467 124.69 0.0143
2013-08-09 2013-06-30 13F CELLDEX THERAPEUTICS INC COM 15117B103 1,153,757 1,153,757 18,010 0.0065
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.